title: Salivary excretion of anticancer drugs.
authors.affiliation: Department of Internal Medicine, University of Kansas School of Medicine-Wichita.
authors.forename: M
authors.initials: M
authors.lastname: Slavik
authors.forename: J
authors.initials: J
authors.lastname: Wu
authors.forename: C
authors.initials: C
authors.lastname: Riley
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood; D004317:Doxorubicin / Q000008:administration & dosage / Q000032:analysis / Q000097:blood; D016903:Drug Monitoring; D005047:Etoposide / Q000008:administration & dosage / Q000032:analysis / Q000097:blood; D005472:Fluorouracil / Q000008:administration & dosage / Q000032:analysis / Q000097:blood; D006801:Humans; D007275:Injections, Intravenous; D008558:Melphalan / Q000008:administration & dosage / Q000032:analysis / Q000097:blood; D008954:Models, Biological; D010306:Parotid Gland / Q000378:metabolism; D012463:Saliva / Q000737:chemistry*
chemical_list: D000970:Antineoplastic Agents; D005047:Etoposide; D004317:Doxorubicin; D008558:Melphalan; D005472:Fluorouracil